Skip to content

Study on the effect of oxycodone in the treatment of visceral pain in parturients undergoing repeat cesarean section

Study on the effect of oxycodone in the treatment of visceral pain in parturients undergoing repeat cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087624
Enrollment
Unknown
Registered
2024-07-31
Start date
2024-08-04
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Experimental Group:Oxycodone + Bilateral TAPB: (PCIA analgesic formula: Oxycodone 50mg, ondansetron 8mg, Normal Saline 100ml
Analgesic pump mode: continuous dose 3ml/h, single dose 3ml, locking time 30min, maximum dose 12ml per hour
TAPB block at the transverse abdominal muscle plane: the ultrasound probe was placed between the anterior axillary line and the midaxillary line of the pregnant woman, and the anatomic position of the
Control Group:Sufentanil + Bilateral TAPB: (PCIA analgesic formula: Sufentanil 100ug, ondansetron 8mg, Normal Saline 100ml
Analgesic pump mode: continuous dose 3ml/h, single dose 3ml, locking time 30min, maximum dose 12ml per hour. TAPB block at the transverse abdominal muscle plane: the ultrasound probe was placed betwee

Sponsors

Jiangsu Provincial People's Hospital, Chongqing Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Elective repeat cesarean section under spinal anesthesia; 2) Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with coagulation dysfunction; 2) Patients with ASA grade III and above; 3) Patients with central systemic diseases; 4) Patients with chronic pain diseases; 5) Patients who take anti-inflammatory and analgesic drugs for a long time; 6) Patients allergic to the drug used in the trial study.

Design outcomes

Primary

MeasureTime frame
Contraction pain level;

Secondary

MeasureTime frame
Degree of incision pain;The onset of pain;Inflammatory index leukocytes, neutrophils, lymphocytes;

Countries

China

Contacts

Public ContactChen qiwei

Jiangsu Provincial People's Hospital, Chongqing Hospital

329966306@qq.com+86 139 8371 5502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 19, 2026